3 Best Pharma Stocks to Buy Right Now
2020 is a wild year to be trading pharmaceutical stocks. With major companies scrambling to develop therapies and vaccines for the coronavirus and many competitors struggling against the economic toll of the pandemic, good bargains are hard to find. Nonetheless, Biogen (NASDAQ: BIIB), Regeneron (NASDAQ: REGN), and Pfizer (NYSE: PFE) are all excellent options to purchase in the short term.
Two of these companies have spent the year working hard to address the pandemic, and their efforts have already borne fruit for shareholders. All three are profitable, and have a manageable debt load. Most of all, these three companies have powerful engines of innovation, and they’ll be firing on all cylinders to grow over the next few years.
Image source: Getty Images.